Costs and benefits of early access to new cancer drugs through the US Food and Drug Administration’s accelerated approval pathway Post date 16 December 2025 ← Opioid prescribing to people on orthopaedic waiting lists during the covid-19 pandemic in England → GP suspended for faking appointments to pick up her children on time